Inotropic Therapy in Acute Circulatory Failure
Various definitions of “acute circulatory failure” (ACF) can be given according to the criteria considered as most meaningful (cardiac output, systemic pressures or others). In this article, we will define ACF in terms of inappropriate peripheral (tissular or even better, cellular) oxygen supply. This definition has the advantage to clearly specify that the therapy has to aim to improvement of oxygen tissular delivery, i.e. to optimization of arterial O2 content and O2 transport. Optimization of arterial O2 content is not the subject of this discussion, but O2 transport is the basis of our topic. O2 transport does not only depend on cardiac output: considerations about microcirculation and rheology would be here of primary importance but, once again, fall outside our topic. In treating ACF we have to take into account the quality of tissular perfusion.
KeywordsDopamine Cardiomyopathy Epinephrine Cardiol Renin
Unable to display preview. Download preview PDF.
- 5.Baumann G (1986) Acute effects of dopexamine hydrochloride, in comparison to dobutamine and nitroprussiate in patients with chronic cardiac failure. X World congress of cardiology, Washington DC, Abstract book, 1077Google Scholar
- 6.Foulds RA, Magrini F, Zanchetti A (1986) The renovascular effects of dopexamine hydrochloride, a dopaminergic and β2 adrenergic agonist. X World congress of cardiology, Washington DC, Abstract book, 1151Google Scholar
- 7.Colardyn F (1986) Acute and long-term haemodynamic effects of dopexamine hydrochloride in patients with chronic cardiac failure. X World congress of cardiology, Washington DC, Abstract book, 1980Google Scholar
- 9.Sonnenblick EH, Grose R, Strain J, Zelcer AA, LeJemtel T (1986) Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure. Circulation 73:III-162–167Google Scholar
- 10.Uretsky BF, Valdes AM, Reddy PS (1986) Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure : hemodynamic effects and clinical efficacy of MDL 17,043. Circulation 73:III-219–229Google Scholar
- 12.Renard M, Liebens I, Walter M, Bernard R (1986) Acute and long-term response to oral pimobendan (UD-CG115) in patients with congestive heart failure. X World congress of cardiology, Washington DC, Abstract book, 1177Google Scholar
- 18.Massari FM, Foresti A, Valentini R, Bertoni T, De Martini M, Lotto A (1986) Clinical and hemodynamic evaluation of amrinone in acute myocardial infarction complicated by cardiogenic shock. X World congress of cardiology, Washington DC, Abstract book, 2524Google Scholar
- 21.Installé E, Gonzalez M, Jacquemart JL, Guillaume JE, Anton E, Tremouroux J (1986) Efficacy of enoximone (MDL 17043) in refractory post-cardiac surgery low output syndrome. Acta Pharmacol Toxicol 59, Suppl V:182Google Scholar
- 22.Installé E, Gonzalez M, Jacquemart JL, Collard P, Roulette F, Pourbaix S, Tremouroux J. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine, and ni-troprusside in patients with severe congestive heart failure. Am J Cardiol (in press)Google Scholar
- 24.Likoff MJ, Ulrich S, Hakki A, Iskandrian AS (1986) Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 57:1328–1334PubMedCrossRefGoogle Scholar